健康大视野·医学分册2023,Issue(13) :8-9,12.DOI:10.3969/j.issn.1005-0019.2023.13.004

芬吗通(2/10)联合二甲双胍预处理治疗多囊卵巢综合症的临床分析

翟焕玲
健康大视野·医学分册2023,Issue(13) :8-9,12.DOI:10.3969/j.issn.1005-0019.2023.13.004

芬吗通(2/10)联合二甲双胍预处理治疗多囊卵巢综合症的临床分析

翟焕玲1
扫码查看

作者信息

  • 1. 金乡县人民医院,山东 济宁 272200
  • 折叠

摘要

目的:探讨多囊卵巢综合征临床治疗中运用芬吗通(2/10)联合二甲双胍预处理的治疗效果及用药安全性分析.方法:回顾性分析,选取2021年2月-2022年6月间门诊收治的多囊卵巢综合征患者100例,随机分为单一组50例,芬吗通(2/10)治疗,剩余50例纳入联合组单一组治疗基础上联合二甲双胍预处理治疗.对比药物治疗效果及用药过程中的药物安全性.结果:联合组性激素指标、内分泌指标、受孕率和排卵率优于单一组;用药不良反应发生低于单一组,(P<0.05).结论:芬吗通(2/10)联合二甲双胍预处理治疗多囊卵巢综合症

Abstract

Objective To investigate the efficacy and safety of fentanyl (2/10) combined with metformin in the treatment of polycystic ovary syndrome (PCOS) .Methods: A total of 100 women with polycystic ovary syndrome (PCOS) from February 2002 to June 2022 were randomly divided into two groups: control group (N = 50) and control group (N = 50) . The 2021 were treated with fentanyl (2/10), the remaining 50 patients were enrolled in the Combined Group with metformin pretreatment on the basis of single treatment. The efficacy and safety of drug therapy were compared. Results:The sex hormone index, Endocrine Index, pregnancy rate and ovulation rate of the combined group were better than those of the single group, and the incidence of adverse drug reactions was lower than that of the single group (p < 0.05) .Conclusion:FENMOTOP(2/10) combined with metformin preconditioning was effective and safe in the treatment of polycystic ovary syndrome.

关键词

多囊卵巢综合征/芬吗通(2/10)/二甲双胍预处理

Key words

Polycystic ovary syndrome, fentanyl (2/10) , metformin pretreatment

引用本文复制引用

出版年

2023
健康大视野·医学分册
中国保健协会

健康大视野·医学分册

ISSN:1005-0019
参考文献量11
段落导航相关论文